Scinai Immunotherapeutics (SCNI) Net Shares Issued and Repurchased (2020)

Scinai Immunotherapeutics (SCNI) reported Net Shares Issued and Repurchased of $10.3 million for Q2 2020.

Scinai Immunotherapeutics (SCNI) Net Shares Issued and Repurchased (2020) Analysis & Trends

Scinai Immunotherapeutics (SCNI) has 1 years of Net Shares Issued and Repurchased data on file, last reported at $10.3 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Oculis Holding AG 67,583.17 Bn 67,582.89 Bn - -
2 Nanobiotix 1,947.22 Bn 1,947.15 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - -
4 BeOne Medicines 473.21 Bn 468.42 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 123.29 Bn 116.04 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 70.05 Bn 61.29 Bn 3.31 Bn -
7 Belite Bio 63.09 Bn 63.09 Bn - -
8 Argenx Se 56.63 Bn 51.45 Bn 1.41 Bn -
9 Revolution Medicines 37.79 Bn 37.79 Bn - -
10 Scinai Immunotherapeutics 3.84 Bn 724.05 Mn -1.12 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2020 10.34 Mn
Jun 30, 2020 10.34 Mn